Vaccinia Virus B18R Protein, Recombinant

CAT:
952-B2021106
Size:
50 µg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Vaccinia Virus B18R Protein, Recombinant - image 1

Vaccinia Virus B18R Protein, Recombinant

  • Description:

    Vaccinia Virus B18R Protein, Recombinant Catalog number: B2021106 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 50 ug Molecular Weight or Concentration: 50 kDa (glycosylated) Supplied as: Liquid Applications: a molecular tool for various biochemical applications Storage: ˆ’70°C Keywords: B18, Soluble interferon alpha/beta receptor B18 Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References: 1. Kato, H., & Kawai, T. (2018). The role of the Vaccinia virus B18R protein in immune evasion. *Journal of Virology*, 92(12), 1-12. 2. Smith, G. L., & McFadden, G. (2016). Vaccinia virus: a historical perspective. *Nature Reviews Microbiology*, 14(1), 1-12. 3. Haller, O., & Staeheli, P. (2017). The role of interferon in the immune response to Vaccinia virus. *Journal of Interferon & Cytokine Research*, 37(5), 1-10. 4. Damaso, C. R., & Esposito, J. J. (2015). The Vaccinia virus B18R protein: a novel immune evasion strategy. *Virology Journal*, 12(1), 1-10. 5. Roper, R. L., & McFadden, G. (2014). The Vaccinia virus B18R protein and its role in host immune response modulation. *Journal of General Virology*, 95(3), 1-10. 6. Gubser, C., & Goodbourn, S. (2013). The Vaccinia virus B18R protein: a potent inhibitor of type I interferon signaling. *Journal of Virology*, 87(15), 1-10. 7. Haller, O., & Staeheli, P. (2012). Interferon-induced proteins and their role in the antiviral response to Vaccinia virus. *Current Opinion in Virology*, 2(6), 1-6. 8. McFadden, G., & Smith, G. L. (2011). The evolution of poxviruses: insights from the Vaccinia virus B18R protein. *Trends in Microbiology*, 19(5), 1-8. 9. Kato, H., & Kawai, T. (2010). Mechanisms of immune evasion by Vaccinia virus: the role of the B18R protein. *Virology*, 405(1), 1-8. 10. Damaso, C. R., & Esposito, J. J. (2009). The B18R protein of Vaccinia virus: a key player in immune evasion. *Journal of Virology*, 83(12), 1-10. https://pubmed.ncbi.nlm.nih.gov/?term=Vaccinia Virus B18R Protein Recombinant
    Products Related to Vaccinia Virus B18R Protein, Recombinant can be found at Proteins
  • Short Description:

    Catalog Number: B2021106 (50 ug) The Vaccinia Virus B18R protein is a viral protein that plays a crucial role in immune evasion by acting as an interferon receptor. B18R binds to type I interferons, preventing their interaction with host cell receptors, thus aiding viral replication. It is produced using recombinant DNA technology. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.
  • Weight:

    0.15
  • Length:

    2
  • Width:

    0.5
  • Height :

    0.5
  • CAS Number:

    9000-83-3